Metformin (generic), Glucophage Newswire (Page 8)

Metformin (generic), Glucophage Newswire (Page 8)

Comprehensive Real-Time News Feed for Metformin (generic), Glucophage. (Page 8)

Results 141 - 160 of 1,298 in Metformin (generic), Glucophage

  1. By Canadian Pharmacy :: Best Deal On MetforminRead the original story

    Nov 20, 2016 | Hernando Today

    Best Place To Order Cheapest Glucophage Generic without prescription. Glucophage is used to treat a type of diabetes mellitus called type 2 diabetes.

    Comment?

  2. Free Viagra Samples a " Costo Glucophage 500 mg Farmacia a " Fast Order DeliveryRead the original story

    Nov 20, 2016 | Hernando Today

    How To order Generic Glucophage Pills. Glucophage is used to treat a type of diabetes mellitus called type 2 diabetes.

    Comment?

  3. Kanadensiska Healthcare P N tet Apotek :: Ink p Billigaste...Read the original story

    Nov 19, 2016 | Hernando Today

    Basta apotek for att kopa Metaglip Goteborg. Generic Metaglip is an orally administered antidiabetic treatment used to help manage type 2 diabetes.

    Comment?

  4. Purchase 500 mg Glucovance generic / Canadian Healthcare Discount PharmacyRead the original story

    Nov 19, 2016 | Hernando Today

    How To Get Glucovance with Discount. Glucovance is an oral medication used to treat type 2 diabetes.

    Comment?

  5. Metformin alters gut microbiota composition in diabetesRead the original story w/Photo

    Nov 19, 2016 | PhysOrg Weblog

    Jacobo de la Cuesta-Zuluaga, from the Vidarium-Nutrition Health and Wellness Research Center in Medellin, Columbia, and colleagues examined the correlation between type 2 diabetes, metformin , and gut microbiota among Columbian adults. Analyses focused on 28 participants diagnosed with diabetes and 84 sex-, age-, and body mass index-matched participants without diabetes.

    Comment?

  6. S ker Apotekk p Generika. K pa Glyburide and Metformin BilligasteRead the original story

    Nov 17, 2016 | Hernando Today

    Glyburide and Metformin Sverige. Glucovance (glyburide and metformin) is an oral medication used to treat type 2 diabetes. Managing type 2 diabetes has never been easier than with Generic Glucovance. You can order Generic Glucovance here for a fraction of the regular price!

    Comment?

  7. Order Glucovance 2.5 mg Canada / Good Quality DrugsRead the original story

    Nov 17, 2016 | Hernando Today

    Best Place To Buy Generic Glucovance without prescription. Glucovance is an oral medication used to treat type 2 diabetes.

    Comment?

  8. Role of Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorsRead the original story w/Photo

    Nov 17, 2016 | US Pharmacist

    ABSTRACT: Diabetes is one of the most prevalent disease states affecting Americans today. Diabetes is a complex disease, and understanding each drug class and its role in managing diabetes is crucial to pharmacy practice.

    Comment?

  9. Breaking a Vicious CycleRead the original story

    Nov 17, 2016 | US Pharmacist

    US Pharm . 2016;41 :1. Much is made these days about the mind-body connection, particularly when it comes to healthcare.

    Comment?

  10. Better definition of 'pre-diabetes' can help identify those at risk for long-term complicationsRead the original story w/Photo

    Nov 17, 2016 | PhysOrg Weblog

    Defining pre-diabetes based on hemoglobin A1C, a common test that determines a long-term average blood sugar level, is the most accurate predictor of who will go on to develop long-term complications from diabetes, new Johns Hopkins Bloomberg School of Public Health research suggests. Professional organizations do not agree on how to define pre- diabetes , a condition that indicates a patient is likely to develop type 2 diabetes and its potential complications in the near future.

    Comment?

  11. Global Antidiabetics Market Is Driven by Increase in the Prevalence of DiabetesRead the original story w/Photo

    Nov 16, 2016 | SBWire

    The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus.

    Comment?

  12. GI adverse events up with GLP-1 receptor agonistsRead the original story w/Photo

    Nov 16, 2016 | PhysOrg Weblog

    Glucagon-like peptide-1 receptor agonists are associated with increased risk of gastrointestinal adverse events , with risk varying based on dose, background medications, and type of GLP-1 RA, according to research published online Nov. 9 in Diabetes, Obesity and Metabolism . Karolin Bettge, from St. Josef Hospital in Bochum, Germany, and colleagues conducted a systematic literature review and selected 32 phase 3 clinical trials with GLP-1 RAs.

    Comment?

  13. Case StudiesRead the original story

    Nov 14, 2016 | Pharmacy Times

    CASE 1 MJ is a 67-year-old woman who presents to the emergency department complaining of abdominal pain and frequent diarrhea for the past 3 days. She also reports loss of appetite and is febrile, with a temperature of 101.1F.

    Comment?

  14. Fatty Liver Treatment Market Revenue, Opportunity, Forecast and Value Chain 2016-2026Read the original story

    Nov 13, 2016 | Emailwire.com

    Fatty liver disease is the most common liver dysfunction in which the triglyceride fat accumulates in liver cells. The fatty liver disease is caused due to obesity and excessive alcohol intake.

    Comment?

  15. Metformin Hydrochloride Market Growth Opportunities, Driving Factors...Read the original story

    Nov 13, 2016 | Emailwire.com

    Metformin Hydrochloride Market analysis is provided for global market including development trends by regions, competitive analysis of the metformin hydrochloride market. Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs.

    Comment?

  16. Why an investor at Andreessen Horowitz thinks software is the...Read the original story w/Photo

    Nov 12, 2016 | Greenwich Citizen

    It's not exactly surprising that a partner of a venture capital firm with a tagline that "software is eating the world" thinks the same could be said for the drug industry. Vijay Pande, a general partner at Andreessen Horowitz, runs the firm's bio fund.

    Comment?

  17. a Cho/fibre diet reduces and a Mufa diet increases postprandial...Read the original story

    Nov 11, 2016 | CiteULike

    A CHO/fibre diet reduces and a MUFA diet increases postprandial lipaemia in type 2 diabetes: no supplementary effects of low-volume physical training. The aim of the study was to evaluate the effects of a supervised physical training added to a healthy diet-rich in either carbohydrate and fibre or monounsaturated fatty acids -on postprandial dyslipidaemia, an independent cardiovascular risk factor particularly relevant in type 2 diabetes .

    Comment?

  18. Zealand Pharma Release: Issues Positive Opinion Recommending Suliqua ...Read the original story

    Nov 10, 2016 | BioSpace

    Zealand Pharma today announced that Sanofi has received a positive opinion from the Committee for Medicinal Product for Human Use of the European Medicines Agency recommending approval of Suliqua , the once-daily titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 diabetes. CHMP recommended the use of Suliqua in combination with metformin for the treatment of adults with type 2 diabetes mellitus to improve glycemic control when this has not been provided by metformin alone or metformin combined with another oral glucose lowering medicinal product or with basal insulin.

    Comment?

  19. Development of a wearable medical device for type 2 diabetesRead the original story w/Photo

    Nov 11, 2016 | PhysOrg Weblog

    Although effective for the treatment of diabetes, exercise is sometimes difficult for overweight or elderly people. A new wearable medical device developed by Kumamoto University has been found to effect visceral fat loss and improve blood glucose .

    Comment?

  20. European advisory committee backs Sanofi's diabetes med SuliquaRead the original story w/Photo

    Nov 11, 2016 | Seeking Alpha

    The European Medicines Agency's Committee for Medicinal Products for Human Use adopts a positive opinion recommending approval of Sanofi's Suliqua for the treatment of adults with type 2 diabetes. The specific indication is the use of Suliqua, in combination with metformin, for the treatment of adult type 2 diabetics to improve glycemic control when treatment with metformin alone or in combination with another oral glucose-lowering medicine or basal insulin fails to do the job.

    Comment?